Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies into the occurrence of soluble antigen-antibody complexes in disease. IV. Correlation between the rheumatoid biologically active factor and the clinical features of rheumatoid arthritis.

× No keyword cloud information.

19 in total

Review 1. THE ROLE OF ANTIGEN-ANTIBODY COMPLEXES IN DISEASE.

Authors: F J DIXON
Journal: Harvey Lect Date: 1963

2. 1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors: M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal: Bull Rheum Dis Date: 1958-12

3. Pathogenesis of serum sickness.

Authors: F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal: AMA Arch Pathol Date: 1958-01

4. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis.

Authors: C M PLOTZ; J M SINGER
Journal: Am J Med Date: 1956-12 Impact factor: 4.965

5. Studies into the occurrence of soluble antigen-antibody complexes in disease. 3. Rheumatoid arthritis and other human diseases.

Authors: R Baumal; I Broder
Journal: Clin Exp Immunol Date: 1968-07 Impact factor: 4.330

6. Studies into the occurrence of soluble antigen--antibody complexes in disease. I. A biological assay for soluble complexes.

Authors: R Baumal; I Broder
Journal: Clin Exp Immunol Date: 1968-07 Impact factor: 4.330

7. Immunologic factors and clinical activity in systemic lupus erythematosus.

Authors: P H Schur; J Sandson
Journal: N Engl J Med Date: 1968-03-07 Impact factor: 91.245

8. Acute poststreptococcal glomerulonephritis: immune deposit disease.

Authors: A F Michael; K N Drummond; R A Good; R L Vernier
Journal: J Clin Invest Date: 1966-02 Impact factor: 14.808

9. Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis.

Authors: C Krishnan; M H Kaplan
Journal: J Clin Invest Date: 1967-04 Impact factor: 14.808

10. The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces.

Authors: W T Kniker; C G Cochrane
Journal: J Exp Med Date: 1968-01-01 Impact factor: 14.307

5 in total

1. Cryoimmunoglobulinemia in rheumatoid arthritis. Significance in serum of patients with rheumatoid vasculitis.

Authors: M Weisman; N Zvaifler
Journal: J Clin Invest Date: 1975-09 Impact factor: 14.808

2. Inhibitory effect of rheumatoid sera on cell damage by lymphocytes.

Authors: I G Barnett; I C MacLennan
Journal: Ann Rheum Dis Date: 1972-09 Impact factor: 19.103

3. Studies into the occurrence of soluble antigen-antibody complexes in disease. VI. Further characterization of the biological and physical properties of the rheumatoid biologically active factor (RBAF).

Authors: I Broder; E Tackaberry; M Urowitz; L Russell; R Baumal
Journal: Clin Exp Immunol Date: 1974-05 Impact factor: 4.330

4. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.

Authors: H S Luthra; F C McDuffie; G G Hunder; E A Samayoa
Journal: J Clin Invest Date: 1975-08 Impact factor: 14.808

5. Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis.

Authors: Tomas Weitoft; Johan Rönnelid; Azita Sohrabian; Linda Mathsson-Alm; Monika Hansson; Ann Knight; Jörgen Lysholm; Martin Cornillet; Karl Skriner; Guy Serre; Anders Larsson
Journal: Ann Rheum Dis Date: 2018-06-12 Impact factor: 19.103

5 in total